BOISE — Sen. Brandon Shippy, R-New Plymouth, is proposing to put a 10-year pause on certain types of vaccines that were used ...

This would reverse progress toward curbing drug shortages. AstraZeneca scrapped plans to invest $558.3 million in its vaccine ...

Then there were safety concerns. The AstraZeneca and Johnson & Johnson vaccines were linked to a rare, but serious, blood clot in the brain and their use was restricted to certain groups.

University of Idaho researchers found that the COVID-19 vaccine does not have any adverse effects on a mother’s breast milk.

and AbbVie stock (up 15%), Johnson & Johnson’s stock performance has been muted. This is attributed to declining Covid-19 vaccine sales, falling Remicade revenue, and increased competition for ...

It’s how we know the mRNA Covid-19 vaccines caused the heart condition myocarditis in about one in 50,000 people and that the Johnson & Johnson Covid-19 vaccine caused dangerous clotting in ...

Johnson & Johnson (JNJ) beat on fourth quarter and full-year 2024 ... That includes slowing COVID-19 vaccine sales — a theme ...

COVID-19 vaccines were not associated with increased risk for thyroid diseases but were associated with increased risk for exacerbated hypothyroidism.

In this article, we are going to take a look at where Johnson & Johnson (NYSE:JNJ) stands against the other stocks. Wall Street ended the first trading day of the week on a mixed note, with the ...

So far, Health Canada has approved the Moderna Spikevax, Pfizer-BioNTech Cominarty, AstraZeneca Vaxevria and Janssen (Johnson & Johnson) vaccines for use in Canada. More on Canada More videos CRA ...